StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Earnings

Freenome's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2026
$183.50M
EPS, Q3 FY2026
$0.58
Latest guidance
Issued
Nov 10, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Freenome's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close$183.50M–$0.58Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Freenome's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenueFY2026$192.00M – $194.00M–NewNov 10, 2026

Guidance history

Every forecast Freenome put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2026total revenueFY2026$192.00M – $194.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Freenome filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?